The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic

Biopolymers
Youla S Tsantrizos

Abstract

The virally encoded serine protease NS3/NS4A is essential to the life cycle of the hepatitis C virus (HCV), an important human pathogen causing chronic hepatitis, cirrhosis of the liver, and hepatocellular carcinoma. Until very recently, the design of inhibitors for the HCV NS3 protease was limited to large peptidomimetic compounds with poor pharmacokinetic properties, making drug discovery an extremely challenging endeavor. In our quest for the discovery of a small-molecule lead that could block replication of the hepatitis C virus by binding to the HCV NS3 protease, the critical protein-polypeptide interactions between the virally encoded NS3 serine protease and its polyprotein substrate were investigated. Lead optimization of a substrate-based hexapeptide, guided by structural data, led to the understanding of the molecular dynamics and electronic effects that modulate the affinity of peptidomimetic ligands for the active site of this enzyme. Macrocyclic beta-strand scaffolds were designed that allowed the discovery of potent, highly selective, and orally bioavailable compounds. These molecules were the first HCV NS3 protease inhibitors reported that inhibit replication of HCV subgenomic RNA in a cell-based replicon assay at...Continue Reading

References

Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M HijikataK Shimotohno
Aug 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M HoughtonQ L Choo
Apr 20, 1967·Biochemical and Biophysical Research Communications·I Schechter, A Berger
Oct 4, 1995·Biochemical and Biophysical Research Communications·D W KimJ Choe
Apr 1, 1994·Journal of Virology·H MizushimaK Shimotohno
Jun 1, 1994·Journal of Virology·E SantoliniN La Monica
Jul 11, 1998·Journal of Virology·P GallinariR De Francesco
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·M Llinàs-BrunetD Lamarre
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·M Llinàs-BrunetD Lamarre
Jun 22, 1999·The Journal of Biological Chemistry·S R LaPlanteM Llinàs-Brunet
Dec 11, 1999·Current Topics in Microbiology and Immunology·R De Francesco, C Steinkühler
Jul 15, 2000·Seminars in Liver Disease·A Wasley, M J Alter
Oct 31, 2000·Bioorganic & Medicinal Chemistry Letters·M Llinàs-BrunetD Lamarre
Mar 7, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A GrakouiC M Rice
May 29, 2001·Current Medicinal Chemistry·C SteinkühlerV G Matassa
Jun 15, 2001·ILAR Journal·R E LanfordG Klimpel
Jul 10, 2001·The Journal of Organic Chemistry·M A PoupartY S Tsantrizos
Aug 2, 2001·Nature Medicine·D F MercerN M Kneteman
Oct 26, 2002·Journal of Hepatology·Xavier FornsRobert H Purcell
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Geetanjali ChanderKelly A Gebo
Jul 29, 2003·Expert Opinion on Investigational Drugs·Michelle P WalkerZhi Hong
Oct 28, 2003·Nature·Charles M Rice
Nov 26, 2003·Antiviral Research·Ralf BartenschlagerSandra Sparacio

❮ Previous
Next ❯

Citations

Apr 24, 2012·Chemical Reviews·Reem SmoumMorris Srebnik
May 24, 2012·Expert Opinion on Investigational Drugs·Sudeep TanwarGeoffrey M Dusheiko
Aug 29, 2009·Bioorganic & Medicinal Chemistry Letters·Amogh BoloorJuan M Betancort
Jun 10, 2009·Biochimica Et Biophysica Acta·María Victoria FloresRomuald Corbau
Jan 9, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·UNKNOWN Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology
Jun 30, 2006·Bioorganic & Medicinal Chemistry Letters·Laurent MugherliMaxim Y Balakirev
Jun 6, 2006·Bioorganic & Medicinal Chemistry Letters·Christopher J CreightonAllen B Reitz
Jul 11, 2006·Antiviral Research·Zhuhui HuangJohn A Secrist
Jul 7, 2012·Journal of Pharmaceutical and Biomedical Analysis·Carl A BusaccaChris H Senanayake
Jul 26, 2011·Bioorganic & Medicinal Chemistry·Anna LampaAnja Sandström
Dec 1, 2009·Antiviral Research·Michela BollatiMartino Bolognesi
May 9, 2006·Current Opinion in Chemical Biology·Marco BetzHarald Schwalbe
May 14, 2011·Antiviral Chemistry & Chemotherapy·Lynne Cregar-HernandezStephen A Margosiak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.